Dear Colleagues, It is with great pride and enthusiasm that I welcome you to the “Bridging Immunology and Therapy: New Perspectives on MIMIDs.” In today’s rapidly advancing medical landscape, multisystemic immune-mediated inflammatory diseases (MIMIDs) are transforming the way we understand, diagnose, and manage chronic conditions. With rheumatology as a central focus, this congress brings together key insights from immunology and a broad spectrum of specialties—including gastroenterology, pulmonology, ophthalmology, cardiology, dermatology, and more. This meeting is more than a collection of lectures—it is a dynamic plat form for clinical advancement, interdisciplinary collaboration, and mean ingful engagement with the pharmaceutical and biotech sectors. As the demand for targeted immune therapies grows, it is critical that we join forces to exchange knowledge, challenge assumptions, and shape the future of immune-driven healthcare. We are proud to foster an environment where cutting-edge research is shared, cross-specialty dialogue is encouraged, and actionable insights are generated. Your presence is not only valued—it is vital to driving progress for our patients. I look forward to an impactful and inspiring congress—one that strengthens collaboration, advances science, and ultimately improves care for those living with MIMIDs. Let’s make it better—together. 

Warm regards